BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26908836)

  • 1. Clinical course of sly syndrome (mucopolysaccharidosis type VII).
    Montaño AM; Lock-Hock N; Steiner RD; Graham BH; Szlago M; Greenstein R; Pineda M; Gonzalez-Meneses A; Çoker M; Bartholomew D; Sands MS; Wang R; Giugliani R; Macaya A; Pastores G; Ketko AK; Ezgü F; Tanaka A; Arash L; Beck M; Falk RE; Bhattacharya K; Franco J; White KK; Mitchell GA; Cimbalistiene L; Holtz M; Sly WS
    J Med Genet; 2016 Jun; 53(6):403-18. PubMed ID: 26908836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis type VII (Sly syndrome) - What do we know?
    Grant CL; López-Valdez J; Marsden D; Ezgü F
    Mol Genet Metab; 2024 Mar; 141(3):108145. PubMed ID: 38301529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.
    Giugliani R; Gonzalez-Meneses A; Scarpa M; Burton B; Wang R; Martins E; Oussoren E; Hennermann JB; Chabrol B; Grant CL; Sun A; Durand C; Hetzer J; Malkus B; Marsden D; Merritt Ii JL
    Orphanet J Rare Dis; 2024 May; 19(1):189. PubMed ID: 38715031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII - a European caregiver survey.
    Morrison A; Oussoren E; Friedel T; Cruz J; Yilmaz N
    Orphanet J Rare Dis; 2019 Nov; 14(1):254. PubMed ID: 31727109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy.
    Furlan F; Rovelli A; Rigoldi M; Filocamo M; Tappino B; Friday D; Gasperini S; Mariani S; Izzi C; Bondioni MP; Gellera C; Venerando A; Villa N; Del Carmen Rodriguez Perez M; Pavan F; Biondi A; Parini R
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):128. PubMed ID: 30442200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis VII in Brazil: natural history and clinical findings.
    Giugliani R; Barth AL; Dumas MRC; da Silva Franco JF; de Rosso Giuliani L; Grangeiro CHP; Horovitz DDG; Kim CA; de Araújo Leão EKE; de Medeiros PFV; Miguel DSCG; Moreira MESA; Dos Santos HMGP; da Silva LCS; da Silva LR; de Souza IN; Nalin T; Garcia D
    Orphanet J Rare Dis; 2021 May; 16(1):238. PubMed ID: 34022924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidosis type VII as a cause of recurrent non-immune hydrops fetalis.
    Cheng Y; Verp MS; Knutel T; Hibbard JU
    J Perinat Med; 2003; 31(6):535-7. PubMed ID: 14711113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.
    Tomatsu S; Orii KO; Vogler C; Grubb JH; Snella EM; Gutierrez MA; Dieter T; Sukegawa K; Orii T; Kondo N; Sly WS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14982-7. PubMed ID: 12403825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.
    Sly WS; Vogler C; Grubb JH; Zhou M; Jiang J; Zhou XY; Tomatsu S; Bi Y; Snella EM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2205-10. PubMed ID: 11226217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome).
    Tomatsu S; Montaño AM; Dung VC; Grubb JH; Sly WS
    Hum Mutat; 2009 Apr; 30(4):511-9. PubMed ID: 19224584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of the molecular and clinical characteristics of the mucopolysaccharidosis type VII Iberian cohort.
    Gónzalez-Meneses A; Pineda M; Bandeira A; Janeiro P; Ruiz MÁ; Diogo L; Cancho-Candela R
    Orphanet J Rare Dis; 2021 Oct; 16(1):445. PubMed ID: 34686181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII.
    Vervoort R; Islam MR; Sly WS; Zabot MT; Kleijer WJ; Chabas A; Fensom A; Young EP; Liebaers I; Lissens W
    Am J Hum Genet; 1996 Mar; 58(3):457-71. PubMed ID: 8644704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
    Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysis.
    Zielonka M; Garbade SF; Kölker S; Hoffmann GF; Ries M
    Genet Med; 2017 Sep; 19(9):983-988. PubMed ID: 28383542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
    Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
    Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.
    Qi Y; McKeever K; Taylor J; Haller C; Song W; Jones SA; Shi J
    Clin Pharmacokinet; 2019 May; 58(5):673-683. PubMed ID: 30467742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency.
    den Hollander NS; Kleijer WJ; Schoonderwaldt EM; Los FJ; Wladimiroff JW; Niermeijer MF
    Ultrasound Obstet Gynecol; 2000 Jul; 16(1):87-90. PubMed ID: 11084974
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.